ArticleCureus2022
Clinicoradiological Characteristics of Gastric Metastases: A Single Center Retrospective Study.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gastric Metastasis from Gastric-Type Mucinous Adenocarcinoma of Uterine Cervix: A Case Report.Journal of the Korean Society of Radiology · 2024Article
- Clinicopathological features and differential diagnosis of gastric metastases.World journal of surgical oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith recent advances in treatment, gastric metastases are increasingly becoming the subject of diagnostic imaging. On the other hand, it is difficult to detect gastric metastasis on CT finding images. PURPOSE: To characterize the CT findings of gastric metastasis and investigate its treatment method and natural history in patients. MATERIALS AND
methodsWe retrospectively reviewed the CT findings of 15 patients diagnosed with gastric metastasis between April 2003 and December 2019 in our hospital. The location, size, and shape of the tumors on CT were evaluated. Moreover, their medical records, characteristics, complications, treatment options, and natural course were evaluated.
resultsOf the 15 patients with gastric metastasis, 9 were male and 6 were female. The median age was 74 (55-87) years. Gastric metastasis was diagnosed simultaneously with primary cancer in five patients. In other patients, the median interval time from the date of primary cancer diagnosis to gastric metastasis diagnosis was 27 (10-259) months. CT findings revealed that the gastric metastasis had a median size of 18 (12-135) mm and was mainly located in the middle third of the stomach. In addition, most patients had a submucosal tumor (SMT) pattern, followed by diffuse wall thickness and polypoid patterns (11 [73.3%], 3 [20.0%], and 1 [6.7%], respectively). The median time to death after gastric metastasis diagnosis was 112 (17-883) days.
conclusionThe SMT pattern in the middle third of the stomach is the characteristic CT finding of gastric metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.